Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

97
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
97
CRISPR01:59

CRISPR

52.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality, Cost, and Timeliness of Cancer Treatment in Medicare Advantage and Traditional Medicare.

JAMA internal medicine·2026
Same author

Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?

JCO oncology practice·2026
Same author

Shared antibiofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans.

Genetics·2026
Same author

Negative control of Candida albicans biofilm formation by combined action of white-opaque regulator Wor2 and biofilm regulator Bcr1.

G3 (Bethesda, Md.)·2026
Same author

When Priority Review No Longer Prioritizes.

JCO oncology practice·2026
Same author

Use of Low-Value Cancer Care in Practices Acquired by Private Equity Firms.

Journal of the National Cancer Institute·2026

Related Experiment Video

Updated: Aug 7, 2025

CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans
09:56

CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans

Published on: November 14, 2018

12.0K

Correction: Targeted Genetic Changes in Candida albicans Using Transient CRISPR-Cas9 Expression

Manning Y Huang, Max V Cravener, Aaron P Mitchell

    Current Protocols
    |March 9, 2023
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
    08:37

    A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

    Published on: April 30, 2018

    7.7K
    Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
    09:04

    Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

    Published on: September 25, 2019

    8.3K

    Related Experiment Videos

    Last Updated: Aug 7, 2025

    CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans
    09:56

    CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans

    Published on: November 14, 2018

    12.0K
    A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
    08:37

    A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

    Published on: April 30, 2018

    7.7K
    Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
    09:04

    Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

    Published on: September 25, 2019

    8.3K